The DOI matches its Crossref record; the references it cites are not checked yet.
Lipid ratios and obesity indices are effective predictors of metabolic syndrome in women with polycystic ovary syndrome
Open accessAbstract
Background: Insulin resistance (IR) is common in women with polycystic ovary syndrome (PCOS). Metabolic syndrome (MS) involves IR, arterial hypertension, dyslipidemia, and visceral fat accumulation. Therefore, fatness indices and blood lipid ratios can be considered as screening markers for MS. Our study aimed to evaluate the predictive potential of selected indirect metabolic risk parameters to identify MS in PCOS. Methods: This cross-sectional study involved 596 women aged 18–40 years, including 404 PCOS patients diagnosed according to the Rotterdam criteria and 192 eumenorrheic controls (CON). Anthropometric and blood pressure measurements were taken, and blood samples were collected to assess glucose metabolism, lipid parameters, and selected hormone levels. Body mass index (BMI), waist-to-height ratio (WHtR), homeostasis model assessment for insulin resistance index (HOMA-IR), visceral adiposity index (VAI), lipid accumulation product (LAP), non-high-density lipoprotein cholesterol (non-HDL-C), and triglycerides-to-HDL cholesterol ratio (TG/HDL-C) were calculated. MS was assessed using the International Diabetes Federation (IDF) and the American Heart Association/National Heart, Lung, and Blood Institute (AHA/NHLBI) criteria. Results: MS prevalence was significantly higher in PCOS versus CON. Patients with both MS and PCOS had more unfavorable anthropometric, hormonal, and metabolic profiles versus those with neither MS nor PCOS and versus CON with MS. LAP, TG/HDL-C, VAI, and WHtR were the best markers and strongest indicators of MS in PCOS, and their cut-off values could be useful for early MS detection. MS risk in PCOS increased with elevated levels of these markers and was the highest when TG/HDL-C was used. Conclusions: LAP, TG/HDL-C, VAI, and WHtR are representative markers for MS assessment in PCOS. Their predictive power makes them excellent screening tools for internists and enables acquiring accurate diagnoses using fewer MS markers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Recently, the WHtR has been suggested as a representative marker for metabolic syndrome assessment in PCOS cases (23).”
From The waist-to-height ratio is a good predictor for insulin resistance in women with polycystic ovary syndrome (2024) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
The citation lists are queued
They are fetched later and appear here then.
References 55 · Cited by 32
Research works printed but not linked: 4
- Abruzzese GA, 2017, Horm Metab Res, 49, 23
- Guleken Z, 2021, J Med Physiol Biophys, 71, 5
- 10.1007/BF03401401 · doi:10.1007/bf03401401
- Borrayo G, 2018, Acta Endocrinol, 14, 261
Metadata
- Authors
- Kałużna, M., Czlapka-Matyasik, M., Kompf, P., Moczko, J., Wachowiak-Ochmańska, K., Janicki, A., Samarzewska, K., Ruchała, M., & Ziemnicka, K.
- Affiliations
- Poznan University of Medical Sciences (PL)
- Department of Human Nutrition and Dietetics, Poznan University of Life Sciences, Poznan, Poland
- Heliodor Swiecicki Clinical Hospital (PL)
- Corresponding author
- Kałużna, Małgorzata
- ORCID
- Venue
- Therapeutic Advances in Endocrinology and Metabolism
- Publisher
- SAGE Publications
- Published
- 2022-01
- Volume
- 13
- Pages
- 20420188211066699-20420188211066699
- ISSN
- 2042-0188 (ISSN-L)
- 2042-0196
- PMC
- PMC8755932
- OpenAlex
- W4206551005
- Cited by
- 32
- References
- 55
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 7 · 2023: 5 · 2022: 1
- FWCI
- 5.06
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Therapeutic Advances in Endocrinology and Metabolism (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu (502-14-02221355-41164)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- polycystic ovary syndrome, metabolic syndrome, metabolic syndrome screening, lipid ratios, triglyceride to HDL cholesterol ratio, lipid accumulation product, visceral adiposity index, waist-to-height ratio, insulin resistance, obesity indices, women
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lipid ratios and obesity indices are effective predictors of metabolic syndrome in women with polycystic ovary syndrome. https://app.cochat.ai/papers/10.1177/20420188211066699
- The paper
- Kałużna, M., Czlapka-Matyasik, M., Kompf, P., Moczko, J., Wachowiak-Ochmańska, K., Janicki, A., Samarzewska, K., Ruchała, M., & Ziemnicka, K. (2022). Lipid ratios and obesity indices are effective predictors of metabolic syndrome in women with polycystic ovary syndrome. Therapeutic Advances in Endocrinology and Metabolism. https://doi.org/10.1177/20420188211066699
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
